Greater ease of use and reduced morbidities and cost drive the global trend towards non-invasive respiratory support for premature infants, such as Bubble continuous-positive-airway-pressure (Bubble-CPAP). However, approximately half of infants supported initially on this technology fail and must receive mechanical ventilation or likely die. To bridge the gap between Bubble-CPAP and mechanical ventilation, Seattle-PAP was developed as a low cost device with greater respiratory support capabilities.
- Awardee Christopher Howard, Seattle Children’s Hospital
- Type Pre-Seed
- Website http://www.seattlechildrens.org